【礼来(LLY.US)Omvoh药物获加拿大卫生部批准用于治疗克罗恩病】智通财经APP获悉,礼来公司(LLY.US)周二宣布,其药物Omvoh(mirikizumab,米瑞奇珠单抗)已获得加拿大卫生部批准,用于治疗克罗恩病患者。目前,Omvoh已被批准用于两种炎症性肠病的治疗,包括溃疡性结肠炎。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.